» Articles » PMID: 8062194

Low Grade Transitional Cell Carcinoma of the Bladder. Cytologic Diagnosis by Key Features As Identified by Logistic Regression Analysis

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 1994 Sep 1
PMID 8062194
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bladder cytology is being used increasingly to detect and monitor early stage bladder cancer. Because of the lack of significant cytomorphologic atypia in low grade transitional cell carcinomas (TCCs), there often is great difficulty in separating these neoplastic cells from benign urothelial cells.

Methods: In an attempt to increase diagnostic sensitivity, 82 bladder wash specimens, which included 33 low grade TCCs and 49 nonneoplastic lesions, were reviewed retrospectively. With a stepwise logistic regression analysis, three key cytomorphologic criteria useful in the separation of low grade TCC from benign urothelium were identified.

Results: The key cytologic criteria were increased nuclear/cytoplasmic ratios, irregular nuclear borders, and cytoplasmic homogeneity. By using contingency tables, these three criteria combined had a sensitivity of 45% and a specificity of 98% in the diagnosis of low grade transitional cell carcinoma. If any two of the criteria were present, there was a sensitivity of 85% and a specificity of 96%.

Conclusions: By using these three criteria, the diagnosis of TCC can be made with a high degree of accuracy in bladder wash specimens.

Citing Articles

Impact of Implementing Paris System on Diagnostic Precision and Management of Urinary Bladder Neoplasms.

Arora S, Singh P, Kumar A, Srivastava N, Kolte S, Yadav A Indian J Surg Oncol. 2024; 15(2):225-235.

PMID: 38741619 PMC: 11088611. DOI: 10.1007/s13193-023-01864-z.


Diagnosis of Low-Grade Urothelial Neoplasm in the Era of the Second Edition of the Paris System for Reporting Urinary Cytology.

Christofidis K, Moulavasilis N, Fragkiadis E, Goutas D, Lazaris A, Mitropoulos D Diagnostics (Basel). 2023; 13(16).

PMID: 37627884 PMC: 10453841. DOI: 10.3390/diagnostics13162625.


URINE CYTOLOGY AND AXILLARY TESTING FOR INTERPRETATION AND FOLLOW-UP OF URINARY TUMORS.

Kalogeraki A, Tamiolakis D, Mamoulakis C Acta Clin Croat. 2023; 61(3):505-510.

PMID: 37492363 PMC: 10364101. DOI: 10.20471/acc.2022.61.03.16.


Usefulness of the Urine Methylation Test (Bladder EpiCheck) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells-An Institutional Study.

Pena K, Riu F, Hernandez A, Guilarte C, Badia J, Parada D J Clin Med. 2022; 11(13).

PMID: 35807141 PMC: 9267544. DOI: 10.3390/jcm11133855.


A Differential Diagnosis Model For Diabetic Nephropathy And Non-Diabetic Renal Disease In Patients With Type 2 Diabetes Complicated With Chronic Kidney Disease.

Yang Z, Feng L, Huang Y, Xia N Diabetes Metab Syndr Obes. 2019; 12:1963-1972.

PMID: 31686878 PMC: 6777431. DOI: 10.2147/DMSO.S223144.